Evaluation of antiseizure drug efficacy and tolerability in the rat lamotrigine-resistant amygdala kindling model.

Metcalf, Cameron S; Huff, Jennifer; Thomson, Kyle E; Johnson, Kristina; Edwards, Sharon F; Wilcox, Karen S

Metcalf, Cameron S; Huff, Jennifer; Thomson, Kyle E; Johnson, Kristina; Edwards, Sharon F; Wilcox, Karen S.

Afiliación

Metcalf CS; Anticonvulsant Drug Development Program, Department of Pharmacology and Toxicology University of Utah Salt Lake City UT USA.
Huff J; Anticonvulsant Drug Development Program, Department of Pharmacology and Toxicology University of Utah Salt Lake City UT USA.
Thomson KE; Anticonvulsant Drug Development Program, Department of Pharmacology and Toxicology University of Utah Salt Lake City UT USA.
Johnson K; Anticonvulsant Drug Development Program, Department of Pharmacology and Toxicology University of Utah Salt Lake City UT USA.
Edwards SF; Anticonvulsant Drug Development Program, Department of Pharmacology and Toxicology University of Utah Salt Lake City UT USA.
Wilcox KS; Anticonvulsant Drug Development Program, Department of Pharmacology and Toxicology University of Utah Salt Lake City UT USA.

Epilepsia Open ; 4(3): 452-463, 2019 Sep.

Article en En | MEDLINE | ID: mdl-31440726

Palabras clave

animal models; antiseizure drugs; kindling; pharmacoresistant epilepsy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Epilepsia Open Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google